- All
- #InspiredByLife
- Bioeconomy
- Biosimilars
- BREXIT
- Cell & Gene Therapies
- Circular Economy
- Climate Change
- COVID-19
- Factsheet
- Genome editing
- HEALTHCARE BIOTECH
- INDUSTRIAL BIOTECH
- Innovation
- Intellectual Property
- Interview
- Jobs & Growth
- NATIONAL ASSOCIATIONS
- News
- Other
- Patient Bio-Forum
- Position Paper
- Press release
- Public Procurement
- Regulatory Efficiency
- Report
- SME
- SME Platform
- WHAT IF
- White paper
July 26, 2021
July 20, 2021
July 3, 2021
We, the undersigned CEOs of global biotechnology companies and associations have a social responsibility to work with other stakeholders to ensure that COVID vaccines and treatments get to the patients in the world who most need them.
June 16, 2021
June 14, 2021
June 7, 2021
June 1, 2021
May 27, 2021
2021_05_H_O_EMA-EuropaBio bilateral meeting_Agenda items 1 & 2 2021_05_H_O_EMA-EuropaBio bilateral meeting_Agenda items 4 & 5
May 25, 2021
EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
May 12, 2021
IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge. In the long run, the waiver proposal undermines the existing vaccine eco-system built in the crisis urgency.
April 28, 2021
EuropaBio is delighted to announce that the Lithuanian Biotechnology Association joins EuropaBio
